Moderna and Lonza collaborate to manufacture COVID-19 vaccine

Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus and additional Moderna products in the future.

“Moderna, Inc. and Lonza Ltd. today announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) and additional Moderna products in the future.”socma.org

• 1 source
• socma.orgSOCMA Member News Archives - Page 27 of 30 - Society of Chemical Manufacturers & Affiliates | Society of Chemical Manufacturers & AffiliatesJun 2, 2020

Summarized from public sources; check the original articles before acting on it.